We searched in the PubMed and EMBASE for articles related ... · The terms ‘microbial keratitis’, ‘infective keratitis’ and ‘suppurative keratitis’ are all used to describe
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
International Journal of Scientific & Engineering Research Volume 9, Issue 10, October-2018 323 ISSN 2229-5518
1. Whitcher JP, Srinivasan M, Upadhyay MP. Corneal blindness: a global perspective. Bull World Health Organ. 2001;79:214-221.
2. Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol. 2012;96:614-618.
3. World Health Organization. Causes of blindness and visual impairment. Available at: http://www.who.int/blindness/ causes/en. Accessed December 7, 2016.
4. Gupta N, Tandon R, Gupta SK, et al. Burden of corneal blindness in India. Indian J Community Med. 2013;38: 198-206.
5. Gonzales CA, Srinivasan M, Whitcher JP, Smolin G. Incidence of corneal ulceration in Madurai district, South India. Ophthalmic Epidemiol. 1996;3:159-166.
6. Dart JK, Stapleton F, Minassian D. Contact lenses and other risk factors in microbial keratitis. Lancet. 1991;338:650-653.
7. Green M, Apel A, Stapleton F. Risk factors and causative organisms in microbial keratitis. Cornea. 2008;27:22-27.
8. Keay L, Stapleton F, Schein O. Epidemiology of contact lensrelated inflammation and microbial keratitis: a 20-year perspective. Eye Contact Lens. 2007;33(6 Pt 2):346-353. discussion 362-363.
9. Thylefors B. Epidemiological patterns of ocular trauma. Aust N Z J Ophthalmol. 1992;20:95-98.
10. Sheng XL, Li HP, Liu QX, et al. Prevalence and associated factors of corneal blindness in Ningxia in northwest China. Int J Ophthalmol. 2014;7:557-562.
11. Saha S, Banerjee D, Khetan A, Sengupta J. Epidemiological profile of fungal keratitis in urban population of West Bengal, India. Oman J Ophthalmol. 2009;2:114-118.
12. Nirmalan PK, Katz J, Tielsch JM, et al. Ocular trauma in a rural south Indian population: the Aravind Comprehensive Eye Survey. Ophthalmology. 2004;111:1778-1781.
13. Spencer, W. H. (1985) Cornea, Chapter 3. In: Ophthalmic Pathology: An Atlas and Textbook, Vol. 1, 3rd ed., W. B. Saunders Company, Philadelphia.
14. Spear, P. (1985) Glycoproteins specified by Herpes simplex virus. In: The Herpes Viruses (B. Roizman, ed.), Plenum, New York, Vol. 3, p. 315.
15. Liesegang, T. J. (1992) Biology and molecular aspects of Herpes simplex and varicella-zoster virus infections. Ophthalmology 99:781–799.
16. Liesegang, T. J. (1985) Corneal complications from Herpes zoster ophthalmicus. Ophthalmology 92:316–324.
17. Wilhelmus, K. R. (1997) Syphilitic interstitial keratitis. Chapter 10. In: Cornea and External Disease: Clinical Diagnosis and Management (Krachmer, J. H., Mannis, M. J., and Holland, E. J., eds.), Mosby-Year Book, Inc., St. Louis.
18. Patterson, A. (1966) Interstitial keratitis. Br. J. Ophthalmol. 50:612–613. 19. Allen, J. H. and Byers, J. L. (1960) The pathology of ocular leprosy: cornea. Arch.
Ophthalmol. 64:80–84. 20. Sakla, A. A., Donnelly, J. J., Lok, J. B., Khatami, M., and Rockey, J. H. (1986) Punctate
keratitis induced by subconjunctivally injected microfilariae of Onchocerca lienalis. Arch. Ophthalmol. 104:894–898.
21. Von Noorden, G. K. and Buck, A. A. (1968) Ocular Onchocerciasis. Arch. Ophthalmol. 80:26–34.
22. Cogan, D. S. (1945) Syndrome of nonsyphilitic interstitial keratitis and vestibuloauditory symptoms. Arch. Ophthalmol. 33:144–149.
23. Lucchese, N. and Tessler, H. (1981) Keratitis associated with chronic iridocyclitis. Am. J. Ophthalmol. 92:717–721.
24. Aasuri, M. K., Madhukar, R., Sharma, S., and Rao, G. N. (1999) Co-occurrence of pneumococcal keratitis and dacryocystitis. Cornea 18:273–276.
25. O’Brien, T. P. (1997) Bacterial keratitis, chapter 94. In: Cornea and External Disease: Clinical Diagnosis and Management, Vol. II (Krachmer, et al., eds), J. H. Mosby-Year Book, Inc., St. Louis.
26. Wilson, S. E., Bannan, R. A., McDonald, M. B., and Kaufman, H. E. (1990) Corneal trauma and infection caused by manipulation of the eyelashes after application of mascara. Cornea 9:181–182.
27. Marioneaux, S. J., Cohen, E. J., Arentsen, J. J., and Laibson, P. R. (1991) Moraxella keratitis. Cornea 10:21–24.
28. Choudhuri, K. K., Sharma, S., Garg, P., and Rao, G. N. (2000) Clinical and microbiological profile of Bacillus keratitis. Cornea 19:301–306.
29. Zaidman, G. W., Coudron, P., and Piros, J. (1990) Listeria monocytogenous keratitis. Am. J. Ophthalmol. 109:334–339.
30. Elliott, D. C. (1951) An interpretation of the ocular manifestations of leprosy. Ann. NY Acad. Sci. 54:84.
31. Pillat, A. (1930) Leprosy bacilli in the scraping from the diseased cornea in a leper and comments on keratitis punctata superficialius laprosa. Arch. Ophthalmol. 6:306.
32. Baum, J., Barza, M., Weinstein, P., Groden, J., and Aswad, M. (1988) Bilateral keratitis as a manifestation of Lyme disease. Am. J. Ophthalmol. 105:75–77
33. McLeod SD, Kolahdouz-Isfahani A, Rostamian K, et al. The role of smears, cultures, and antibiotic sensitivity testing in the management of suspected infectious keratitis. Ophthalmology. 1996;103:23-28.
34. Kim E, Chidambaram JD, Srinivasan M, et al. Prospective comparison of microbial culture and polymerase chain reaction in the diagnosis of corneal ulcer. Am J Ophthalmol. 2008;146:714-723, 723.e711.
35. Chang HY, Chodosh J. Diagnostic and therapeutic considerations in fungal keratitis. Int Ophthalmol Clin. 2011;51:33-42.
36. Badiee P, Nejabat M, Alborzi A, et al. Comparative study of Gram stain, potassium hydroxide smear, culture and nested PCR in the diagnosis of fungal keratitis. Ophthalmic Res. 2010;44:251-256.
37. Zhang W, Yang H, Jiang L, et al. Use of potassium hydroxide, Giemsa and calcofluor white staining techniques in the microscopic evaluation of corneal scrapings for diagnosis of fungal keratitis. J Int Med Res. 2010;38:1961-1967.
38. Gopinathan U, Sharma S, Garg P, Rao GN. Review of epidemiological features, microbiological diagnosis and treatment outcome of microbial keratitis: experience of over a decade. Indian J Ophthalmol. 2009;57:273-279.
39. American Academy of Ophthalmology Cornea/External Disease Panel. Preferred Practice Pattern Guidelines. Bacterial Keratitis. San Francisco, CA: American Academy of Ophthalmology; 2013. Available at: www.aao.org/ppp.
40. Darougar S, Wishart MS, Viswalingam ND. Epidemiological and clinical features of primary herpes simplex virus ocular infection. Br J Ophthalmol. 1985;69:2-6.
41. El-Aal AM, El Sayed M, Mohammed E, et al. Evaluation of herpes simplex detection in corneal scrapings by three molecular methods. Curr Microbiol. 2006;52:379-382.
42. Nielsen E, Heegaard S, Prause JU, et al. Fungal keratitisd improving diagnostics by confocal microscopy. Case Rep Ophthalmol. 2013;4:303-310.
44. Das S, Samant M, Garg P, et al. Role of confocal microscopy in deep fungal keratitis. Cornea. 2009;28:11-13.
45. Kanavi MR, Javadi M, Yazdani S, Mirdehghanm S. Sensitivity and specificity of confocal scan in the diagnosis of infectious keratitis. Cornea. 2007;26:782-786.
46. Vaddavalli PK, Garg P, Sharma S, et al. Role of confocal microscopy in the diagnosis of fungal and acanthamoeba keratitis. Ophthalmology. 2011;118:29-35.
47. Konstantopoulos A, Kuo J, Anderson D, Hossain P. Assessment of the use of anterior segment optical coherence tomography in microbial keratitis. Am J Ophthalmol. 2008;146:534-542.
48. Martone G, Pichierri P, Franceschini R, et al. In vivo confocal microscopy and anterior segment optical coherence tomography in a case of alternaria keratitis. Cornea. 2011;30:449-453.
49. Austin A, Schallhorn J, Geske M, et al. Empiric treatment of bacterial keratitis: an international survey of corneal specialists. Br J Ophthalmol Open. [Accepted for publication].
50. McDonald EM, Ram FS, Patel DV, McGhee CN. Topical antibiotics for the management of bacterial keratitis: an evidence-based review of high quality randomised controlled trials. Br J Ophthalmol. 2014;98:1470-1477.
51. Constantinou M, Daniell M, Snibson GR, et al. Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial. Ophthalmology. 2007;114: 1622-1629.
52. O’Brien TP, Maguire MG, Fink NE, et al. Efficacy of ofloxacin vs. cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group. Arch Ophthalmol. 1995;113:1257-1265.
53. Hyndiuk RA, Eiferman RA, Caldwell DR, et al. Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group. Ophthalmology. 1996;103:1854-1863.
54. Acharya NR, Srinivasan M, Mascarenhas J, et al. The steroid controversy in bacterial keratitis. Arch Ophthalmol. 2009;127:1231.
55. Cohen EJ. The case against the use of steroids in the treatment of bacterial keratitis. Arch Ophthalmol. 2009;127: 103-104.
56. Hindman HB, Patel SB, Jun AS. Rationale for adjunctive topical corticosteroids in bacterial keratitis. Arch Ophthalmol. 2009;127:97-102.
57. Den S, Sotozono C, Kinoshita S, Ikeda T. Efficacy of early systemic betamethasone or cyclosporin A after corneal alkali injury via inflammatory cytokine reduction. Acta Ophthalmol Scand. 2004;82:195-199.
58. Yi K, Chung TY, Hyon JY, et al. Combined treatment with antioxidants and immunosuppressants on cytokine release by human peripheral blood mononuclear cellsdchemically injured keratocyte reaction. Mol Vis. 2011;17:2665-2671.
59. Williams RN, Paterson CA. The influence of topical corticosteroid therapy upon polymorphonuclear leukocyte distribution, vascular integrity and ascorbate levels in endotoxin-induced inflammation of the rabbit eye. Exp Eye Res. 1987;44:191-198.
60. Chung JH, Kang YG, Kim HJ. Effect of 0.1% dexamethasone on epithelial healing in experimental corneal alkali wounds: morphological changes during the repair process. Graefes Arch Clin Exp Ophthalmol. 1998;236: 537-545.
61. Tomas-Barberan S, Fagerholm P. Influence of topical treatment on epithelial wound healing and pain in the early postoperative period following photorefractive keratectomy. Acta Ophthalmol Scand. 1999;77:135-138.
62. Gritz DC, Kwitko S, Trousdale MD, et al. Recurrence of microbial keratitis concomitant with antiinflammatory treatment in an animal model. Cornea. 1992;11:404-408.
63. Gritz DC, Lee TY, Kwitko S, McDonnell PJ. Topical antiinflammatory agents in an animal model of microbial keratitis. Arch Ophthalmol. 1990;108:1001-1005.
64. Herretes S, Wang X, Reyes JM. Topical corticosteroids as adjunctive therapy for bacterial keratitis. Cochrane Database Syst Rev. 2014:CD005430.
65. Blair J, Hodge W, Al-Ghamdi S, et al. Comparison of antibiotic-only and antibiotic-steroid combination treatment in corneal ulcer patients: double-blinded randomized clinical trial. Can J Ophthalmol. 2011;46:40-45.
66. Carmichael TR, Gelfand Y, Welsh NH. Topical steroids in the treatment of central and paracentral corneal ulcers. Br J Ophthalmol. 1990;74:528-531.
67. Srinivasan M, Lalitha P, Mahalakshmi R, et al. Corticosteroids for bacterial corneal ulcers. Br J Ophthalmol. 2009;93: 198-202.
68. Gopinathan U, Garg P, Fernandes M, et al. The epidemiological features and laboratory results of fungal keratitis: a 10-year review at a referral eye care center in South India. Cornea. 2002;21:555-559.
69. O’Day DM, Head WS, Robinson RD, Clanton JA. Corneal penetration of topical amphotericin B and natamycin. Curr Eye Res. 1986;5:877-882.
70. Hariprasad SM, Mieler WF, Lin TK, et al. Voriconazole in the treatment of fungal eye infections: a review of current literature. Br J Ophthalmol. 2008;92:871-878.
71. Walsh TJ, Pappas P, Winston DJ, et al. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. N Engl J Med. 2002;346:225-234.
72. Farooq AV, Shukla D. Herpes simplex epithelial and stromal keratitis: an epidemiologic update. Surv Ophthalmol. 2012;57:448-462.
73. Liesegang TJ, Melton 3rd LJ, Daly PJ, Ilstrup DM. Epidemiology of ocular herpes simplex. Incidence in Rochester, Minn, 1950 through 1982. Arch Ophthalmol. 1989;107: 1155-1159.
74. Reynaud C, Rousseau A, Kaswin G, et al. Persistent impairment of quality of life in patients with herpes simplex keratitis. Ophthalmology. 2017;124:160-169.
75. Morfin F, Thouvenot D. Herpes simplex virus resistance to antiviral drugs. J Clin Virol. 2003;26:29-37.
76. Tsatsos M, MacGregor C, Athanasiadis I, et al. Herpes simplex virus keratitis: an update of the pathogenesis and current treatment with oral and topical antiviral agents. Clin Exp Ophthalmol. 2016;44:824-837.
77. Chou TY, Hong BY. Ganciclovir ophthalmic gel 0.15% for the treatment of acute herpetic keratitis: background, effectiveness, tolerability, safety, and future applications. Ther Clin Risk Manag. 2014;10:665-681.
78. Colin J, Hoh HB, Easty DL, et al. Ganciclovir ophthalmic gel (Virgan; 0.15%) in the treatment of herpes simplex keratitis. Cornea. 1997;16:393-399.
79. Barron BA, Gee L, Hauck WW, et al. Herpetic Eye Disease Study. A controlled trial of oral acyclovir for herpes simplex stromal keratitis. Ophthalmology. 1994;101:1871-1882.
80. Goldblum D, Bachmann C, Tappeiner C, et al. Comparison of oral antiviral therapy with valacyclovir or acyclovir after penetrating keratoplasty for herpetic keratitis. Br J Ophthalmol. 2008;92:1201-1205.